Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hot and cold tumors: Immunological features and the therapeutic strategies
Lianjie Wang, Hui Geng, Yujie Liu, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 100

Showing 1-25 of 100 citing articles:

Cold and hot tumors: from molecular mechanisms to targeted therapy
Bo Wu, Bo Zhang, Bowen Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 46
Transformable Supramolecular Self‐Assembled Peptides for Cascade Self‐Enhanced Ferroptosis Primed Cancer Immunotherapy
He Wang, Di Jiao, Dexiang Feng, et al.
Advanced Materials (2024) Vol. 36, Iss. 21
Closed Access | Times Cited: 29
Advanced Polymeric Nanoparticles for Cancer Immunotherapy: Materials Engineering, Immunotherapeutic Mechanism and Clinical Translation
Wencong Jia, Ye Wu, Yujie Xie, et al.
Advanced Materials (2025)
Closed Access | Times Cited: 4
PD-1/PD-L1 axis: implications in immune regulation, cancer progression, and translational applications
Miguel Á. Ortega, Diego Liviu Boaru, Diego De León-Oliva, et al.
Journal of Molecular Medicine (2024) Vol. 102, Iss. 8, pp. 987-1000
Closed Access | Times Cited: 14
Iridium(III)-Based PD-L1 Agonist Regulates p62 and ATF3 for Enhanced Cancer Immunotherapy
Dongping Deng, Mengmeng Wang, Yan Su, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6810-6821
Closed Access | Times Cited: 9
The Immune Microenvironment in Prostate Cancer: A Comprehensive Review
René Novysedlák, Miray Guney, Majd Al Khouri, et al.
Oncology (2024), pp. 1-25
Open Access | Times Cited: 9
Therapeutic potential of anti-ErbB3 chimeric antigen receptor natural killer cells against breast cancer
J.H. Lee, Jinhoo Song, Wonbeak Yoo, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 2
Open Access | Times Cited: 1
Molecular Basis of Breast Tumor Heterogeneity
Esra Dikoglu, Fresia Pareja
Advances in experimental medicine and biology (2025), pp. 237-257
Closed Access | Times Cited: 1
Inflammation and tumor immune escape in response to DNA damage
Naoe Taira Nihira, Rei Kudo, Tomohiko Ohta
Seminars in Cancer Biology (2025)
Closed Access | Times Cited: 1
A Polymeric mRNA Vaccine Featuring Enhanced Site‐Specific mRNA Delivery and Inherent STING‐Stimulating Performance for Tumor Immunotherapy
Xiaoya Guo, Zhiyu Yang, Zhaopei Guo, et al.
Advanced Materials (2025)
Closed Access | Times Cited: 1
High hypoxia status in pancreatic cancer is associated with multiple hallmarks of an immunosuppressive tumor microenvironment
Hassan Sadozai, Animesh Acharjee, Hateem Zafar Kayani, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
The biological essence of synthetic lethality: Bringing new opportunities for cancer therapy
Meiyi Ge, Jian Luo, Yi Wu, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 8
State-Of-The-Art Advancements on Cancer Vaccines and Biomarkers
Scott Strum, Mads Hald Andersen, Inge Marie Svane, et al.
American Society of Clinical Oncology Educational Book (2024) Vol. 44, Iss. 3
Closed Access | Times Cited: 8
Tumor-intrinsic IFNα and CXCL10 are critical for immunotherapeutic efficacy by recruiting and activating T lymphocytes in tumor microenvironment
Chun‐Chia Cheng, Jungshan Chang, Ai‐Sheng Ho, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 9
Open Access | Times Cited: 8
Is an immune-oriented use of radiation therapy possible? An increasingly open question under the spotlight of immunotherapy
Valentina Zagardo, Mandara Harikar, Gianluca Ferini
ONCOLOGIE (2024) Vol. 26, Iss. 3, pp. 487-491
Open Access | Times Cited: 7
Beyond Anti-PD-1/PD-L1: Improving Immune Checkpoint Inhibitor Responses in Triple-Negative Breast Cancer
Kennady K. Bullock, Ann Richmond
Cancers (2024) Vol. 16, Iss. 12, pp. 2189-2189
Open Access | Times Cited: 7
Inorganic Nanoparticle Functionalization Strategies in Immunotherapeutic Applications
Wei Mao, Hyuk Sang Yoo
Biomaterials Research (2024) Vol. 28
Open Access | Times Cited: 7
The dysadherin/MMP9 axis modifies the extracellular matrix to accelerate colorectal cancer progression
Choong-Jae Lee, Tae‐Young Jang, So-El Jeon, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Advancements in Stimulus-Responsive Co-Delivery Nanocarriers for Enhanced Cancer Immunotherapy
Meng-Ru Zhang, Linlin Fang, Yang Guo, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 3387-3404
Open Access | Times Cited: 5
Highlighting the role of CD44 in cervical cancer progression: immunotherapy’s potential in inhibiting metastasis and chemoresistance
Cayleigh de Sousa, Carla Eksteen, Johann Riedemann, et al.
Immunologic Research (2024) Vol. 72, Iss. 4, pp. 592-604
Open Access | Times Cited: 5
Microphysiological systems as models for immunologically ‘cold’ tumors
Daniela Gaebler, Stephanie J. Hachey, Christopher C.W. Hughes
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 4
Schlafens: Emerging Therapeutic Targets
Ricardo E. Perez, Frank Eckerdt, Leonidas C. Platanias
Cancers (2024) Vol. 16, Iss. 10, pp. 1805-1805
Open Access | Times Cited: 4
Nano-Delivery of Immunogenic Cell Death Inducers and Immune Checkpoint Blockade Agents: Single-Nanostructure Strategies for Enhancing Immunotherapy
Yujeong Moon, Hanhee Cho, Kwangmeyung Kim
Pharmaceutics (2024) Vol. 16, Iss. 6, pp. 795-795
Open Access | Times Cited: 4
Shifting cold to hot tumors by nanoparticle-loaded drugs and products
Irfan Ahmad, Kamil K. Atiyah Altameemi, Mohaned Mohammed Hani, et al.
Clinical & Translational Oncology (2024)
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top